jim fink chief investment strategist reviews

16 Our understanding of the fundamental neuroscience of these issues needs further advancement, but it is clear that brain disorders have many common neurobiological roots. While we can applaud emerging evidence-based digital health solutions as scalable, and often more equitable, these technological solutions are mostly at a population level, not personalized enough, and therefore not able to adequately address the diverse and complex nature of individual needs-a precondition to achieve improved outcomes and added value.Ĭonversely, personalized and biologically inspired technologies struggle to be consistently validated and integrated into clinical workflows and traditional reimbursement models. Scalable, technological solutions to successfully manage these issues have remained mostly piecemeal and siloed-higher education, business, the psychiatry profession, and tech and neurology innovators often do not communicate or collaborate beyond their own disciplines. 14 Approaches to screening, diagnosis, and treatment of mental health disorders are not optimized, compromising our ability to maximize societal brain health and brain skills. Still, there are substantial limitations in our current system of innovation and investing to tackle these brain challenges. Taken together, it can be argued that we are already living in a brain economy-a neuroscience-inspired, knowledge economy. 12 There are new, large-scale public-private partnerships aimed at tackling global mental health ( Healthy Brains Global Initiative) and global Alzheimer disease issues ( Davos Alzheimer’s Collaborative). There also have been positive developments, including increasing dependence on knowledge-intensive economic activity, neuroscience breakthroughs, 8 and developments such as cognitive immunology, 9 increasing attention to workplace mental health,10 a rush of venture capital activity driving innovation, 11 and a higher number of unicorns (companies valued at over USD $1 billion). Dependence upon personal technologies is accelerating, with citizens struggling to keep up with unlimited access to massive amounts of information and data, creating increased stress and anxiety. Global brain challenges are worsening at a time when our economies and societies are becoming more turbulent. 6 Brain Capital constitutes a promising new opportunity within the impact investment category, also known as environmental, social, and governance (ESG) investing. We define Brain Capital Innovation as diverse neuroscience-inspired technologies addressing the confluence of mental health, neurology, education, workforce development, and positive psychology-including resilience, wisdom, and creativity ( Figure 1). In the following article, we put forward our case forBrain Capital as a new investment category placing a premium on technological health care innovations that improve brain health and skills. We need a cross-disciplinary, cross-functional, optimized approach to innovation with a new type of executive, new investment, and new governance.

We need new ways to move the needle on these unprecedented challenges and opportunities. 2Īt the same time, deeply comprehending the human brain will make new achievements possible, with brains that thrive from better understanding mental processes such as creativity, innovation, leadership, and entrepreneurship. If these brain health maladies are not definitively addressed, human communities will have a difficult time sustaining themselves both economically and socially. 1Īdditionally, some of the most persistent social issues-homelessness, crime, death by despair-will be impossible to solve without attention to the root causes and address the treatment and support of individuals with brain disorders and vulnerabilities. Human societies continue to be plagued by brain challenges, from mental health disorders and dementia to learning disabilities, the impact of long COVID, and disparities in educational health care access. We need a new investment opportunity: Brain Capital. To solve existential brain challenges spanning neurology, mental health, education, workforce development, and neuroscience-we need a fresh approach to technologies and investing.

Jim fink chief investment strategist reviews